(VIANEWS) – ORPEA (ORP.PA), listed on the CAC 40 index, experienced an extraordinary surge in its share price over the last 10 sessions – rising 33.33% from EUR0.02 to EUR0.02 as of 15:24 EST Friday afternoon following two consecutive losses.
ORPEA’s CAC 40 index component, ORPEA is currently down by 1.17% to EUR7,363.70 after experiencing a steady downward trend over recent days. ORPEA closed at an all-time low price of EUR0.02, over 99.991% lower than its 52-week high of EUR8.93.
About ORPEA
ORPEA SA is a leading European healthcare provider, specializing in nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals as well as psychiatric hospitals. Our company provides personalized support services, accommodation and meals, daily events, entertainment and therapeutic workshops, catering to an array of conditions including geriatrics, musculoskeletal issues, nervous system conditions, cardiovascular issues, hematology and oncology. ORPEA SA offers home care services, such as housekeeping, daily life assistance and mobility assistance services. ORPEA SA operates across 23 countries across Europe, Latin America, and Asia and serves a range of patients such as geriatric, children, young adults, parent-child relationships, public/private patients. Established in 1989 and headquartered in Puteaux in France.
Yearly Analysis
ORPEA’s stock is currently trading at EUR0.02, significantly less than its 52-week high of EUR8.93 but higher than its 52-week low of EUR0.01. ORPEA expects its sales growth for this year at 8.3% and 7.8% for next year.
Technical Analysis
ORPEA stock has experienced a downward trend recently, falling significantly below both its 50-day and 200-day moving averages. This indicates a potential shift in momentum for ORPEA’s stock, prompting investors to closely watch its future performance. Furthermore, ORPEA’s volume is currently lower than usual, which may also impact price fluctuations.
ORPEA’s intraday variation average has been negative over the past week, positive over the last month, and positive over the last quarter. This could indicate potential shifts in its price action; however, past performance does not guarantee future outcomes.
Stochastic oscillator analysis indicates that ORPEA stock may currently be considered overbought, suggesting an imminent reversal or consolidation event may take place.
ORPEA stock is currently experiencing a difficult period and investors should use caution in their investments by closely following company news and performance indicators to make informed investment decisions.
Quarter Analysis
Revenue GrowthIncreasing year-on-year quarterly revenue growth was at 10.7%, amounting to 4.93B for the last twelve months.
Equity Analysis
According to information available, ORPEA’s trailing 12-month earnings per share (EPS) stands at EUR-4.11 – which indicates a negative earnings per share and indicates the company may not be producing enough profits to sustain operations and return value back to shareholders.
Return on Equity for the trailing twelve month is negative at -445.48% indicating that for every EUR1 invested by shareholders, the company cannot produce a return in profit.
Overall, ORPEA may be experiencing difficulties in terms of profitability and returns for its shareholders. Investors should carefully consider these aspects along with any relevant data before making investment decisions.
More news about ORPEA (ORP.PA).
